Notice Regarding MolDX: Molecular Testing for Solid Organ Allograft Rejection DL38568
Published 08/16/2024
After careful consideration of all the feedback from interested parties regarding the MolDX: Molecular Testing for Solid Organ Allograft Rejection (DL38568) proposed local coverage determination (LCD), we have decided not to finalize the proposed LCD. In the coming months, we intend to issue a new proposed LCD and look forward to further public comment on this very important issue. The Medicare coverage database will be fully updated to reflect this decision next week.